Vertex Pharmaceuticals Corporate Bonds and Current Financial Leverage

VRTX -- USA Stock  

Earnings Report: February 4, 2020  

Vertex Pharmaceuticals financial leverage is the degree to which the firm utilises its fixed-income securities. Companies with high leverage are usually considered to be at financial risk. Vertex Pharmaceuticals financial risk is the risk to Vertex Pharmaceuticals stockholders that is caused by an increase in debt. In other words with a high degree of financial leverage come high interest payments which usually reduces Earnings Per Share (EPS). Also please take a look at analysis of Vertex Pharmaceuticals Fundamentals Over Time.

Vertex Pharmaceuticals Financial Leverage Rating

Not Rated
Total Macroaxis Rating
 
N/A
Average S&P Rating

Vertex Pharmaceuticals Debt to Cash Allocation

The company currently holds 656.95 M in liabilities with Debt to Equity (D/E) ratio of 12.9 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Vertex Pharmaceuticals has Current Ratio of 3.67 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Vertex Pharmaceuticals Inventories Over Time

 
 
Piotroski F Score   
6  Healthy

Vertex Pharmaceuticals Historical Liabilities

Total Debt

Current Sentiment - VRTX

Vertex Pharmaceuticals Investor Sentiment

Most of Macroaxis users are at this time bullish on Vertex Pharmaceuticals Incorpor. What is your outlook on investing in Vertex Pharmaceuticals Incorpor? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Also Currentnly Active

Purchased over 100 shares of
3 days ago
Traded for 24.76
Purchased over 200 shares of
3 days ago
Traded for 53.38
Purchased over 60 shares of
3 days ago
Traded for 78.1
Also please take a look at analysis of Vertex Pharmaceuticals Fundamentals Over Time. Please also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Search macroaxis.com